Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
 
 
October 26, Sunday 2014 12:26 PM       
       HEADLINES: Baby handed over to Jazeera                                              Nine killed in road accident in Assam                                              16 killed in China coal mine collapse                                              Two killed, four injured in US school shooting                                              Iran hangs woman in defiance of international campaign                                              Google exec makes record skydive from edge of space                                              Arsenic linked to lung cancer in Bangladesh                                              Dhoni new owner of HHIL's Ranchi franchise                                              Saina ousted from French Open quarters                                              Kaumudi Facebook
       BUSINESS Next Article: SBI mulls selling bad assets to ARCs in Jan-Mar quarter  
       Ranbaxy recalls over 64,000 bottles of generic Lipitor in US
 
         Posted on :22:10:56 Mar 8, 2014
   
A A
       Last edited on:22:10:56 Mar 8, 2014
         Tags: Ranbaxy, Lipitor in US
 

NEW DELHI: Drug major Ranbaxy Laboratories has recalled over 64,000 bottles of Atorvastatin calcium tablets, a generic version of cholesterol-lowering drug Lipitor, after a complaint of wrong dosage.

The Indian firm, which is reeling under regulatory action from the US Food and Drug Administration (USFDA), recalled the drug after a complaint by a pharmacist who discovered a 20 mg tablet inside a sealed bottle of Atorvastatin 10 mg tablets.

"Ranbaxy Pharmaceuticals is conducting a voluntary recall in the US limited to two lots of Atorvastatin calcium tablets, 10 mg manufactured in India which expire in May 2014," it said in a statement.

The company, majority owned by Japan's Daiichi Sankyo, said it recalled the tablets "because of a remote possibility of the presence of a 20 mg Atorvastatin calcium tablet in a 10 mg bottle."

"This is the basis of the voluntary recall," it added.

To date, Ranbaxy has not received any product complaints related to these batches, the company said.

"Other lot numbers, package sizes and strengths are not affected by this recall. The recall is being conducted at the retail level," it added.

Ranbaxy is withdrawing the lots out of abundant caution, keeping the safety of patients in mind and with full knowledge of the USFDA, it said.

In January, the USFDA prohibited Ranbaxy from producing and distributing drugs for the American market from its Toansa facility in Punjab.

The Toansa plant catered to over 70 per cent of Ranbaxy's requirement for raw material used in medicine formulations. Toansa was the fourth Ranbaxy plant banned by the USFDA.

In September, the USFDA imposed an import alert on Ranbaxy's Mohali plant in Punjab for violating good manufacturing norms.

Ranbaxy's key facilities at Paonta Sahib in Himachal Pradesh and Dewas in Madhya Pradesh have been under a US import alert since 2008.

A A
       BUSINESS
Next Article: SBI mulls selling bad assets to ARCs in Jan-Mar quarter
 
 
BUSINESS HEADLINES
Nissan to recall 9,000 units of Micra, Sunny models in India  
Cafe Coffee Day ordered to slam doors on QNet reps  
Bottlenecks need to be cleared to woo private investments:CEA  
US prosecutor honoured for probe against Infosys  
'Cloud' lifts Microsoft earnings above expectations  
Oil prices down in Asia  
Gold, silver fall on eve of Diwali  
Sensex extends gains, up 212 pts in early trade  
Revised GST Bill in Winter Session: Jaitley  
Festive hiring to help create 4.5 lakh new jobs in Oct-Dec qtr  
Sensex at over 1-wk high, Nifty regains 7,900 mark on reforms  
SpiceJet announces another low-fare offer  
Sitharaman raps Coffee Board for poor performance  
NDA govt reforms aimed at ensuring ease of business: US envoy  
Sensex ends 321 points up; auto stocks up  
US-India trade body to partner in Vibrant Gujarat summit  
Sensex down for 4th straight week;dips 189 pts on global probs  
DLF approaches SAT against Sebi order  
Cisco chief bullish on India  
Sensex rebounds 71 points in early trade on global cues  
Sensex tanks 350 points; consumer durable stocks down  
India fastest growing eCom mkt in APAC; to touch $6 bn by 2015  
Gold imports jump about 5-times in Sep on global price slide  
IndiGo to acquire 250 Airbus A-320 neos  
Ashok Leyland to make electric buses in India  
 
Yes
 
No
 
Don't know
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy